WallStreetZenWallStreetZen

NASDAQ: SGHT
Sight Sciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for SGHT

Based on 3 analysts offering 12 month price targets for Sight Sciences Inc.
Min Forecast
$15.00+99.47%
Avg Forecast
$15.00+99.47%
Max Forecast
$15.00+99.47%

Should I buy or sell SGHT stock?

Based on 3 analysts offering ratings for Sight Sciences Inc.
Strong Buy
Strong Buy
3 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SGHT stock forecasts and price targets.

SGHT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Morgan Stanley
Bottom 11%
11
Strong BuyMaintains$15.00+99.47%2023-01-06
Stifel Nicolaus
Bottom 36%
36
Strong BuyUpgrades$15.00+99.47%2023-01-06
Citigroup
Top 3%
98
Strong BuyMaintains$15.00+99.47%2022-12-12Find out why

1 of 1

Forecast return on equity

Is SGHT forecast to generate an efficient return?
Company
-41.05%
Industry
23.59%
Market
89.83%
SGHT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SGHT forecast to generate an efficient return on assets?
Company
-30.56%
Industry
12.56%
SGHT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SGHT revenue growth forecast

How is SGHT forecast to perform vs Medical Devices companies and vs the US market?
Company
26.09%
Industry
7.08%
Market
8.87%
SGHT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SGHT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SGHT vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
SGHT$7.52$15.00+99.47%Strong Buy
ARAY$3.79N/AN/A
EDAP$9.96$15.33+53.95%Strong Buy
VMD$9.80N/AN/A
AXGN$8.84$17.50+97.96%Strong Buy
View Top Medical Device Stocks

Sight Sciences Stock Forecast FAQ

Is Sight Sciences Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: SGHT) stock is to Strong Buy SGHT stock.

Out of 3 analysts, 3 (100%) are recommending SGHT as a Strong Buy, 0 (0%) are recommending SGHT as a Buy, 0 (0%) are recommending SGHT as a Hold, 0 (0%) are recommending SGHT as a Sell, and 0 (0%) are recommending SGHT as a Strong Sell.

If you're new to stock investing, here's how to buy Sight Sciences stock.

What is SGHT's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: SGHT) forecast ROE is -41.05%, which is considered weak.

What is SGHT's Price Target?

According to 3 Wall Street analysts that have issued a 1 year SGHT price target, the average SGHT price target is $15.00, with the highest SGHT stock price forecast at $15.00 and the lowest SGHT stock price forecast at $15.00.

On average, Wall Street analysts predict that Sight Sciences's share price could reach $15.00 by Jan 6, 2024. The average Sight Sciences stock price prediction forecasts a potential upside of 99.47% from the current SGHT share price of $7.52.

What is SGHT's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: SGHT) forecast ROA is -30.56%, which is lower than the forecast US Medical Devices industry average of 12.56%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.